Phase 3 Heart Disease Trial, Recruiting NCT06399705 Sponsor: Weill Medical College of Cornell University Condition: Heart Disease
Back to Heart Disease

Phase 3 Heart Disease Trial, Recruiting

NCT06399705
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You identify as a member of a minority group
  • You are 18 years old or older
  • You have been found to have blockages in multiple heart arteries or in the main heart artery (left main), and your heart care team has decided that either open-heart bypass surgery (CABG) or a stent procedure (PCI) could reasonably be used to treat it
  • You are able to sign a consent form and agree to all follow-up visits, including filling out quality-of-life questionnaires

Who may not be able to join:

  • You had a serious type of heart attack (STEMI) within the last 3 days
  • You are currently in a state of severe heart failure causing dangerously low blood pressure (cardiogenic shock)
  • You have had a stent procedure (PCI) within the past year, or you have ever had bypass surgery (CABG) at any point in your life
  • Your doctors are planning to do both a stent procedure and bypass surgery together as a combined treatment
  • Your doctors are only planning to treat a single blocked artery (unless it is just the left main artery)
  • You currently need, or are expected to need within 3 years, any other heart procedure besides treating the blocked arteries
  • You are pregnant, or you plan to become pregnant within 1 year of joining the study (women who could become pregnant must have a negative pregnancy test within 1 week before joining)
  • You are unable or unwilling to take two blood-thinning medications together for at least 3 months (or 6 months if you recently had a heart event with elevated troponin levels) (confirm with trial site)
  • You are currently taking part in another clinical study that has not yet finished
  • You have a non-heart-related health condition that means you are not expected to live for at least 3 more years
  • You have any condition that might make it hard to follow the study's requirements over 10 years, such as a cognitive disability, substance use issues, or plans to move abroad

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Registry
ClinicalTrials.gov
Start date
2 October 2024
Est. completion
15 March 2033

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Hierarchical composite of all-cause death and time-averaged change from baseline in generic quality of life using the SF-12v2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov